18 Nov Airborne ® (Effervescent Tablets)
| Company name & Address: | registration number | Batch number(s) | Expiry date | Pack size | First distributed | Re-call Classification | Recall date |
| Cipla Medpro (Pty) Ltd
Building 2 Junxion Park 10 Elephant Lane Century City South Africa 7441 |
N/A | 46112
46113 46114 47544 47545 49153 49154
|
04.2027
04.2027 04.2027 04.2027 04.2027 12.2027 12.2027
|
10’s
10’s 10’s 30’s 30’s 30’s 30’s
|
03.10.2025
02.04.2026 N/A 30.05.2025 08.05.2025 03.03.2026 27.02.2026 |
Class II Type B |
16 November 2026 |
Brief description of the problem (reason for recall)
Cipla Medpro (Pty) Ltd, in consultation with the South African Health Products Regulatory Authority (SAHPRA), is recalling the above batches of Airborne® (Effervescent Tablets) (See attached recall letter).
In accordance with SAHPRA’s directive and associated media release concerning selenium-containing products, the affected batches are being recalled from the market as the product contains selenium and bears legacy packaging artwork containing child-use indications outside of the permitted age range.
Advice for health professionals and distributors:
We request that you refrain from selling or dispensing any pack of the affected batches of Airborne® (Effervescent Tablets) and return them to your supplying warehouse or distributor with immediate effect.
Cipla Medpro (Pty) Ltd. will collect all your stock which will be credited / replaced.
For further product information, please call Cipla Medpro (Pty) Ltd. via our Customer Care line (080 222 6662).
We thank you in advance for your co-operation and apologise for any inconvenience caused.
We apologise for any inconvenience you may have experienced and appreciate your cooperation in this regard.
Proposed action taken and its urgency: A SAHPRA approved recall letter was distributed to all distribution points and the recall process was initiated.